# Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone

> **NCT00965406** · PHASE3 · COMPLETED · sponsor: **University of Monastir** · enrollment: 772 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** GIK and intensive insulin therapy

## Key facts

- **NCT ID:** NCT00965406
- **Lead sponsor:** University of Monastir
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2013-12
- **Final completion:** 2014-06
- **Target enrollment:** 772 (ACTUAL)
- **Last updated:** 2017-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00965406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00965406, "Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00965406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*